BUFFALO, NY — July 15, 2026 — A new case report was published in Volume 13 of Oncoscience on May 22, 2026, titled “Cervical angioleiomyoma: A rare tumor behind persistent menorrhagia and pelvic pain.”

Texas A&M University researchers use a naturally occurring gut chemical to heal the brain after traumatic injury, making post traumatic seizures rarer and harder to trigger while pointing toward a future where epilepsy may be prevented before it begins

AMHERST, Mass. — Chang Liu, associate professor in the Riccio College of Engineering at the University of Massachusetts Amherst, wants people to have access to at-home HIV tests sensitive enough for early diagnosis comparable to—or exceeding—lab standards. A new two-year, $1.3 million award from the National Institutes of Health will help him advance his proof-of-concept work toward commercialization. 

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of Medicine have developed a method to predict which patients with a primary liver cancer called hepatocellular carcinoma (HCC) would most benefit from combination treatment using immunotherapy and a targeted therapy that blocks the growth signals that the tumor depends on. The work, supported in part by the National Institutes of Health, was published online July 14 in the Proceedings of the National Academy of Sciences.

A culmination of 20 years of work by university researchers, health care specialists and architects, "Fable Hospital" presents a model that works with patients and staff -- not against them -- and returns millions in savings over the first two years, and more than $100 million in the first decade. 

Airborne particulate matter from the deserts of North Africa is reaching Europe in ever-increasing quantities. This has implications for health and for solar energy installations. A comprehensive study led by the Paul Scherrer Institute PSI published in Nature shows that this type of pollution is on the rise – a trend that could be further exacerbated by climate change.

WashU Medicine researchers show in mice that their technique to designing medications, in which modular components of anti-cancer drugs are administered separately and assembled in the body using what's known as click chemistry, is more effective than standard treatments at targeting and shrinking tumors.